CLARA GALLO: Open Payments
NPI 1619758778 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 15 payments from 6 companies in 2025. Trend: 2023 $19 · 2024 $37 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 3 | $127 |
| ABBVIE INC. | 4 | $98 |
| Veloxis Pharmaceuticals, Inc. | 2 | $68 |
| Lilly USA, LLC | 3 | $59 |
| GENZYME CORPORATION | 2 | $53 |
| Janssen Biotech, Inc. | 1 | $39 |
Products named: Sucraid, ENVARSUS, DUPIXENT, RINVOQ, TREMFYA, OMVOH, SKYRIZI, MOUNJARO.
Industry payments across NY — which companies pay providers there.
